Literature DB >> 23687184

Print advertisements for Alzheimer's disease drugs: informational and transformational features.

Jonathan Gooblar1, Brian D Carpenter.   

Abstract

PURPOSE: We examined print advertisements for Alzheimer's disease drugs published in journals and magazines between January 2008 and February 2012, using an informational versus transformational theoretical framework to identify objective and persuasive features.
METHODS: In 29 unique advertisements, we used qualitative methods to code and interpret identifying information, charts, benefit and side effect language, and persuasive appeals embedded in graphics and narratives.
RESULTS: Most elements contained a mixture of informational and transformational features. Charts were used infrequently, but when they did appear the accompanying text often exaggerated the data. Benefit statements covered an array of symptoms, drug properties, and caregiver issues. Side effect statements often used positive persuasive appeals. Graphics and narrative features emphasized positive emotions and outcomes. IMPLICATIONS: We found subtle and sophisticated attempts both to educate and to persuade readers. It is important for consumers and prescribing physicians to read print advertisements critically so that they can make informed treatment choices.

Entities:  

Keywords:  Alzheimer’s disease; content analysis; direct-to-consumer advertising; prescription drugs

Mesh:

Substances:

Year:  2013        PMID: 23687184      PMCID: PMC3963824          DOI: 10.1177/1533317513488912

Source DB:  PubMed          Journal:  Am J Alzheimers Dis Other Demen        ISSN: 1533-3175            Impact factor:   2.035


  16 in total

Review 1.  Direct-to-consumer prescription drug advertising: trends, impact, and implications.

Authors:  M S Wilkes; R A Bell; R L Kravitz
Journal:  Health Aff (Millwood)       Date:  2000 Mar-Apr       Impact factor: 6.301

2.  The impact of journal advertisements on prescribers of cholinesterase inhibitors.

Authors:  Justin Sauer; Robert Howard
Journal:  Int J Geriatr Psychiatry       Date:  2002-10       Impact factor: 3.485

3.  A cross-media content analysis of motivational themes in direct-to-consumer prescription drug advertising.

Authors:  Nithima Sumpradit; Frank J Ascione; Richard P Bagozzi
Journal:  Clin Ther       Date:  2004-01       Impact factor: 3.393

4.  Media credibility and informativeness of direct-to-consumer prescription drug advertising.

Authors:  Jisu Huh; Denise E DeLorme; Leonard N Reid
Journal:  Health Mark Q       Date:  2004

5.  Creating demand for prescription drugs: a content analysis of television direct-to-consumer advertising.

Authors:  Dominick L Frosch; Patrick M Krueger; Robert C Hornik; Peter F Cronholm; Frances K Barg
Journal:  Ann Fam Med       Date:  2007 Jan-Feb       Impact factor: 5.166

6.  Direct-to-consumer prescription drug advertising builds bridges between patients and physicians.

Authors:  A F Holmer
Journal:  JAMA       Date:  1999-01-27       Impact factor: 56.272

7.  Toward a more nuanced perception of Alzheimer's disease: designing and testing a campaign advertisement.

Authors:  Baldwin Van Gorp; Tom Vercruysse; Jan Van den Bulck
Journal:  Am J Alzheimers Dis Other Demen       Date:  2012-08-07       Impact factor: 2.035

8.  Direct-to-consumer advertising in oncology: a content analysis of print media.

Authors:  Gregory A Abel; Stephanie J Lee; Jane C Weeks
Journal:  J Clin Oncol       Date:  2007-04-01       Impact factor: 44.544

9.  Australian consumer responses to DTCA and other pharmaceutical company sponsored advertisements.

Authors:  Danika V Hall; Sandra C Jones
Journal:  Aust N Z J Public Health       Date:  2008-10       Impact factor: 2.939

10.  Using a drug facts box to communicate drug benefits and harms: two randomized trials.

Authors:  Lisa M Schwartz; Steven Woloshin; H Gilbert Welch
Journal:  Ann Intern Med       Date:  2009-02-16       Impact factor: 25.391

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.